C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/08 (2006.01) A61K 39/395 (2006.01) A61P 31/22 (2006.01) C07K 14/04 (2006.01)
Patent
CA 2677371
The present invention provides novel antibody sequences that bind Varicella Zoster Virus (VZV) and neutralize VZV infection. The novel sequences can be used for the medical management of VZV infection, in particular for detecting the virus or for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of VZV infection.
La présente invention concerne des séquences novatrices d'anti-corps qui s'accrochent au virus de la varicelle et du zona (VZV) et qui neutralisent l'infection du VZV. Les séquences novatrices peuvent être utilisées pour la gestion médicale de l'infection du VZV, en particulier pour détecter le virus et pour préparer des compositions pharmaceutiques destinées à être utilisées dans le traitement prophylactique et thérapeutique de l'infection du VZV.
Burioni Roberto
Clementi Massimo
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Ribovax Biotechnologies S.a.
LandOfFree
Antibodies specific for varicella zoster virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies specific for varicella zoster virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies specific for varicella zoster virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1698337